For: | Yu XH, Huang J, Ge NJ, Yang YF, Zhao JY. Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report. World J Clin Cases 2021; 9(10): 2281-2288 [PMID: 33869604 DOI: 10.12998/wjcc.v9.i10.2281] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i10/2281.htm |
Number | Citing Articles |
1 |
Chen,MM Yanling, Wang,MM Hantao, Han,PhD Hong, Dong,PhD Yi, Wang,MD Wen-ping. Contrast-enhanced Ultrasound of Undifferentiated Embryonal Sarcoma of the Liver in Adult: Two Cases Report and Literature Revie. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2022; 6(4): 204 doi: 10.37015/AUDT.2022.220014
|
2 |
Peng Jiang, Yan Jiao, Chun-Yuan Niu, Ya-Hui Liu. Undifferentiated embryonal sarcoma of the liver with epithelioid features in an adult patient. Medicine 2021; 100(50): e28265 doi: 10.1097/MD.0000000000028265
|
3 |
Rosemary Vergara, Sarah Khalil, Gitonga Munene. Case report: Multimodal neoadjuvant and adjuvant chemotherapy for hepatic undifferentiated embryonal sarcoma in a young adult. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1004108
|
4 |
Ioannis A. Ziogas, Irving J. Zamora, Harold N. Lovvorn III, Christina E. Bailey, Sophoclis P. Alexopoulos. Undifferentiated Embryonal Sarcoma of the Liver in Children Versus Adults: A National Cancer Database Analysis. Cancers 2021; 13(12): 2918 doi: 10.3390/cancers13122918
|
5 |
Víctor Albarrán, María Luisa Villamayor, Javier Pozas, Jesús Chamorro, Diana Isabel Rosero, María San Román, Patricia Guerrero, Patricia Pérez de Aguado, Juan Carlos Calvo, Coral García de Quevedo, Carlos González, María Ángeles Vaz. Current Landscape of Immunotherapy for Advanced Sarcoma. Cancers 2023; 15(8): 2287 doi: 10.3390/cancers15082287
|
6 |
Italo Fernandes, Douglas Dias e Silva, Vanderlei Segatelli, Renée Zon Filippi, Ana Carolina de Rezende, Paulo Campregher, Fernando Moura, Reynaldo Jesus-Garcia, Roberto Carmagnani Pestana. Microsatellite Instability and Clinical Use in Sarcomas: Systematic Review and Illustrative Case Report. JCO Precision Oncology 2024; (8) doi: 10.1200/PO.24.00047
|